DUPILUMAB EFFICACY AND SAFETY UP TO 52 WEEKS IN ADULT AND ADOLESCENT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM PARTS B AND C OF THE RANDOMIZED, PLACEBO-CONTROLLED, THREE-PART, PHASE 3 LIBERTY EOE TREET STUDY

Evan S. Dellon  ¹     Marc E. Rothenberg  ²     Margaret H. Collins  ²     Ikuo Hirano  ³     Mirna Chehade  ⁴     Alfredo J. Lucendo  ⁵     Jonathan M. Spergel  ⁶     Xian Sun  ⁷     Jennifer D. Hamilton  ⁷     Eric Mortensen  ⁷     Elizabeth Laws  ⁸     Jennifer Maloney  ⁸     Lila Glotfelty  ⁸     Arsalan Shabbir  ^8    
1 University of North Carolina School of Medicine, Chapel Hill, United States
² Cincinnati Children’s Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, United States
³ Northwestern University Feinberg School of Medicine, Chicago, United States
⁴ Mount Sinai Center for Eosinophilic Disorders, New York, United States
⁵ Hospital General de Tomelloso, Tomelloso, Spain
⁶ Children's Hospital of Philadelphia, Philadelphia, United States
⁷ Regeneron Pharmaceuticals Inc., Tarrytown, United States
⁸ Sanofi, Bridgewater, United States

Topic
Oesophagus, Paediatrics

Session
What is the best recipe for EoE: PPI, steroids or monochrome?

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)